5432522025-04-012025-06-305432522025-04-012025-06-30in-capmkt:OtherExpenses1Member5432522025-04-012025-06-30in-capmkt:OtherExpenses2Member5432522025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15432522025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25432522025-04-012025-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543252FAIRCHEMORNOTLISTEDINE0DNW01011Fairchem Organics LimitedMain BoardEquity2025-04-012026-03-312025-08-112025-07-18INRLakhsQuarterlyFirst quarterSingle segmentSpeciality Segment2025-08-1113:30:002025-08-1114:15:00Declaration of unmodified opinionfalsefalseNA2025-04-012025-06-30UnauditedStandalone1310631000133600013119670009072510000161158000601530001005200027354000129843000129581100016156000016156000311500013050004420000011736000000011736000-64400011092000130209000100.90.9000.90.9Notes: <BR> 1. The above unaudited financial results, as reviewed by Audit Committee, are subsequently approved by the Board of Directors at their meetings held on August 11, 2025. The Statutory Auditors have performed limited review of the Company's financial results for the quarter ended June 30, 2025. The Statutory Auditors have expressed an unmodified review conclusion. <BR> <BR> 2. The unaudited financial results of the Company have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and in terms of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <BR> <BR> 3. The figures for the quarter ended March 31, 2025 are the balancing figures between the audited figures in respect of the full financial year and the year to date unaudited figures up to the third quarter for that year. Also, the figures up to the end of third quarter had only been reviewed and not subjected to audit. <BR> <BR> 4. The Company is engaged in the business of manufacturing of speciality chemicals viz. Oleo Chemicals and Intermediate Nutraceuticals. Considering the nature of Company’s business, as well as based on review of operating results by the chief operating decision maker to make decisions about resource allocation and performance measurement, there is only one reportable business segment in accordance with the requirements of IND AS 108 – “Operating Segments”. As almost all the revenue of the Company is from domestic sales, no separate geographical segment is disclosed. <BR> <BR> 5. The Company does not have any subsidiary/associate/joint venture company as on June 30, 2025. <BR> <BR> 6. Investors can view the unaudited financial results of the company for the quarter ended June 30, 2025 on the company's website www.fairchem.in, on the website of the BSE www.bseindia.com and on the website of NSE www.nseindia.com. <BR> Power and Fuel66479000Other Expenses63364000Remeasurement (Losses)/Gains on Post Employment Defined Benefit Plans-860000Incoem Tax Effect216000-6440000-644000UnauditedtrueB S R & Co. LLPtrue2028-07-30